Biologic Patent Protection: When Biosimilars Can Enter the Market
Learn how the BPCIA and the 'patent dance' dictate when biosimilars enter the US market and why biologic patent protection differs from generic drugs.
Tag: biosimilars
Learn how the BPCIA and the 'patent dance' dictate when biosimilars enter the US market and why biologic patent protection differs from generic drugs.